InvestorsHub Logo
Post# of 251702
Next 10
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

Re: DewDiligence post# 210242

Tuesday, 03/28/2017 4:14:13 PM

Tuesday, March 28, 2017 4:14:13 PM

Post# of 251702
Interesting quote on pricing ($37k/yr) from a few months back:

REGN CEO 2/16/17: 'We want to discuss with payers and say, hey, look, we can work together. When a responsible manufacturer comes with a breakthrough product at a price that is really tied to the value delivered, and that everybody can agree on that. Then the payers have to do their part. The payers have to make sure that access, formulary coverage, it's there from the beginning. They don't have these arbitrary delays of six months or this and that. It's there from the beginning. It's not putting these subtle and not so subtle barriers. Believe me, they know every trick in the book. They know if they ask a doctor to fill out a 10-page form just how much of a barrier that is and how many prescriptions that will suppress. And what I want is, I don't want any of those shenanigans. I want coverage. I want access. I want it fair. And what I want to give you in return or in exchange is a breakthrough product at a fair and responsible price. I think that everybody wins when we set that paradigm. I think we can be the new paradigm for how pharma and the payers can actually work together to do the right thing. But it all depends on us being responsible and the payers being responsible.'

And positive reaction by Express Scripts to the pricing:

https://www.forbes.com/sites/matthewherper/2017/03/28/regenerons-new-drug-price-could-disappoint-everyone-heres-why-thats-a-good-thing/#4edfdd765db4

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.